Optimizing Botox regimens in patients with adductor spasmodic dysphonia and essential tremor of voice: A 31‐year experience [PDF]
Objective The purpose of this study was to quantitatively compare the effectiveness of unilateral and bilateral botulinum toxin A (BTX‐A) injections for mitigating undesirable weak/breathy voice quality and dysphagia for patients with adductor spasmodic ...
Amy Stone +7 more
doaj +2 more sources
Characterization of brain microstructural abnormalities in spasmodic dysphonia using diffusion kurtosis imaging [PDF]
To investigate microstructural changes in spasmodic dysphonia (SD) patients applying diffusion kurtosis imaging (DKI) data. DKI (b-values = 0, 1,000, and 2,000 s/mm2) was performed for 20 SD patients and 20 controls.
Fuzhuang Jiang +6 more
doaj +2 more sources
Demographics and coexisting tremor, cervical dystonia and vocal fold disorders in a group of patients with spasmodic dysphonia [PDF]
Selmin Karatayli Ozgursoy +3 more
doaj +4 more sources
Transnasal Endoscopic Injection of Botulinum Toxin in Patients with Adductor Spasmodic Dysphonia [PDF]
Introduction:Adductor Spasmodic Dysphonia (ADSD) is the most common form of spasmodic dysphonia. It encompasses various symptoms affecting voice and speech.
Abdul-Latif Hamdan +3 more
doaj +2 more sources
Comparison of the efficacy and adverse effects of unilateral or bilateral botulinum toxin injections for adductor spasmodic dysphonia: a systematic review and meta-analysis. [PDF]
Liu Y +11 more
europepmc +3 more sources
Laryngeal Manual Therapy: A Preliminary Study to Examine its Treatment Effects in the Management of Muscle Tension Dysphonia [PDF]
The objectives of this study were to determine appropriate acoustic and outcome measures for the evaluation of a method of laryngeal manual therapy (LMT) used in the treatment of patients with muscle tension dysphonia (MTD). The effects of this technique
Shashivadan P Hirani
exaly +2 more sources
Post‐treatment clinical course following botulinum toxin injection therapy for adductor spasmodic dysphonia: Analysis of data from a placebo‐controlled, randomized, double‐blinded clinical trial in Japan [PDF]
Objective Botulinum toxin (BT) therapy is a first‐line treatment for spasmodic dysphonia (SD). However, a detailed chronological course and clinical factors that affect the therapeutic effect have been vague.
Kahori Hirose +7 more
doaj +2 more sources
Pharyngeal Dystonia Mimicking Spasmodic Dysphonia. [PDF]
The aim of this study was to describe the presentation of pharyngeal dystonia (PD), which can occur as a focal or segmental dystonia with a primarily pharyngeal involvement for the discussion of treatment methods for controlling consequent symptoms. PD is specific to speech-related tasks.A retrospective medical record review of four patients with PD ...
Shi LL +4 more
europepmc +4 more sources
Yun-Su Yang
openaire +2 more sources
Altered sensory system activity and connectivity patterns in adductor spasmodic dysphonia. [PDF]
Mantel T +6 more
europepmc +3 more sources

